TOI Past Earnings image   This TOI past earnings page last updated 8/11/2022
TOI Past Earnings
PeriodPast Earnings DateGAAP
Q2 20228/9/2022-0.060
Q1 20225/11/20220.210
Q4 20213/10/2022-0.150
TOI Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/9/20220.06B
Q1 20225/11/20220.06B
Q4 20213/10/20220.05B
Quotes delayed 20 minutes

Email EnvelopeFree TOI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
The Oncology Institute (TOI) is categorized under the Miscellaneous sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

TRTN Past Earnings
TSE Past Earnings
UBP Past Earnings
UPH Past Earnings
URGN Past Earnings
UWMC Past Earnings
VLD Past Earnings
VLDR Past Earnings
VLTA Past Earnings
VMD Past Earnings

TOI Past Earnings Q&A

What was the best and worst TOI past earnings results?
For The Oncology Institute, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest TOI past earnings result in our data set was 0.210/share posted in Q1 2022, while the lowest was in Q4 2021 when TOI posted -0.150/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when TOI reported 0.06B in revenue, while the quarter with the lowest revenue in our data set was Q4 2021 at 0.05B of revenue.

  Suggested answer: There are 3 TOI past earnings results in our data set.

On this page we presented the TOI past earnings date information for The Oncology Institute. Reviewing that TOI Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2022, when TOI posted gaap of 0.210/share. Meanwhile the lowest TOI past earnings result was in Q4 2021, when TOI posted gaap of -0.150/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when TOI reported 0.06B in revenue, while the smallest revenue quarter was Q4 2021 when TOI reported 0.05B in revenue.

Any self directed investor doing their due diligence on TOI or any other given stock can benefit from researching all of the The Oncology Institute past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate The Oncology Institute past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for TOI. Thanks for visiting, and the next time you need to research TOI past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: RUE Historical Stock Prices, EXEO Insider Buying, Funds Holding PACK.

 

TOI Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.